Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury

Diffuse axonal injury (DAI) is the most common and significant pathological features of traumatic brain injury (TBI). However, there are still no effective drugs to combat the formation and progression of DAI in affected individuals. FK506, also known as tacrolimus, is an immunosuppressive drug, whi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Med Rep
Egile Nagusiak: Huang, Ting-Qin, Song, Jin-Ning, Zheng, Feng-Wei, Pang, Hong-Gang, Zhao, Yong-Lin, Gu, Hua, Zhao, Jun-Jie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2017
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5428482/
https://ncbi.nlm.nih.gov/pubmed/28339015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.6350
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak